Morning Briefing
Summaries of health policy coverage from major news organizations
TB Medication Variations In Private Markets Could Harm Treatment Efforts, Study Says
A wide variation in the dosages and forms of medicines prescribed by private physicians to patients with tuberculosis (TB) in developing countries could lead to the development of more drug-resistant strains of the bacterial infection, according to a study published online Wednesday in PLoS One, the Financial Times reports (Jack, 5/4).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
